Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination

被引:3
|
作者
Boudreau, Carolyn M. [1 ,2 ]
Burke IV, John S. [2 ]
Roederer, Alexander L. [1 ,2 ]
Gorman, Matthew J. [2 ]
Mundle, Sophia [3 ]
Lingwood, Daniel [2 ]
Delagrave, Simon [4 ]
Sridhar, Saranya [3 ]
Ross, Ted M. [5 ]
Kleanthous, Harry [6 ]
Alter, Galit [2 ]
机构
[1] Harvard Univ, Program Virol, Div Med Sci, Boston, MA 02115 USA
[2] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[3] Sanofi Pasteur Inc, Discovery North Amer, Cambridge, MA 02139 USA
[4] Ring Therapeut, Cambridge, MA 02139 USA
[5] Univ Georgia, Athens, GA 30602 USA
[6] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA
关键词
IMMUNE-COMPLEXES; GAMMA RECEPTOR; AFFINITY; MOUSE; DIVERSIFICATION; SUSCEPTIBILITY; AUTOIMMUNITY; INHIBITION; ACTIVATION; INFECTION;
D O I
10.1016/j.xcrm.2023.100975
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Under the ever-present threat of a pandemic influenza strain, the evolution of a broadly reactive, neutralizing, functional, humoral immune response may hold the key to protection against both circulating and emerging influenza strains. We apply a systems approach to profile hemagglutinin-and neuraminidase-specific humor -al signatures that track with the evolution of broad immunity in a cohort of vaccinated individuals and validate these findings in a second longitudinal cohort. Multivariate analysis reveals the presence of a unique pre-ex-isting Fcg-receptor-binding antibody profile in individuals that evolved broadly reactive hemagglutination inhibition activity (HAI), marked by the presence of elevated levels of pre-existing FCGR2B-binding antibodies. Moreover, vaccination with FCGR2B-binding antibody-opsonized influenza results in enhanced antibody titers and HAI activity in a murine model. Together, these data suggest that pre-existing FCGR2B binding antibodies are a key correlate of the evolution of broadly protective influenza-specific antibodies, providing insight for the design of next-generation influenza vaccines.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Liver-mediated factor IX expression by AAV8 vector and pre-existing neutralizing antibody in cynomolgus monkey
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Keiji, Terao
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    HUMAN GENE THERAPY, 2008, 19 (10) : 1195 - 1196
  • [32] Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination
    Wild, Katharina
    Smits, Maike
    Killmer, Saskia
    Strohmeier, Shirin
    Neumann-Haefelin, Christoph
    Bengsch, Bertram
    Krammer, Florian
    Schwemmle, Martin
    Hofmann, Maike
    Thimme, Robert
    Zoldan, Katharina
    Boettler, Tobias
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [33] Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination
    Katharina Wild
    Maike Smits
    Saskia Killmer
    Shirin Strohmeier
    Christoph Neumann-Haefelin
    Bertram Bengsch
    Florian Krammer
    Martin Schwemmle
    Maike Hofmann
    Robert Thimme
    Katharina Zoldan
    Tobias Boettler
    Nature Communications, 12
  • [34] Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques
    Jaworski, Juan Pablo
    Bryk, Peter
    Brower, Zachary
    Zheng, Bo
    Hessell, Ann J.
    Rosenberg, Alexander F.
    Wu, Tong Tong
    Sanz, Ignacio
    Keefer, Michael C.
    Haigwood, Nancy L.
    Kobie, James J.
    PLOS ONE, 2017, 12 (02):
  • [35] Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population
    Liu, Xiaoqing
    Liu, Yuan
    Zhang, Yanjun
    Chen, Zhihui
    Tang, Ziwei
    Xu, Qingqiang
    Wang, Yue
    Zhao, Ping
    Qi, Zhongtian
    PLOS ONE, 2013, 8 (03):
  • [36] YELLOW FEVER VACCINATION IN MALAYA BY SUBCUTANEOUS INJECTION AND MULTIPLE PUNCTURE - HAEMAGGLUTININ-INHIBITING ANTIBODY RESPONSES IN PERSONS WITH AND WITHOUT PRE-EXISTING ANTIBODY
    SMITH, CEG
    TURNER, LH
    MCMAHON, DA
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1963, 29 (01) : 75 - &
  • [37] Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
    Nakagama, Yu
    Candray, Katherine
    Kaku, Natsuko
    Komase, Yuko
    Rodriguez-Funes, Maria-Virginia
    Dominguez, Rhina
    Tsuchida, Tomoya
    Kunishima, Hiroyuki
    Nagai, Etsuko
    Adachi, Eisuke
    Ngoyi, Dieudonne Mumba
    Yamasue, Mari
    Komiya, Kosaku
    Hiramatsu, Kazufumi
    Uemura, Naoto
    Sugiura, Yuki
    Yasugi, Mayo
    Yamagishi, Yuka
    Mikamo, Hiroshige
    Shiraishi, Satoshi
    Izumo, Takehiro
    Nakagama, Sachie
    Watanabe, Chihiro
    Nitahara, Yuko
    Tshibangu-Kabamba, Evariste
    Kakeya, Hiroshi
    Kido, Yasutoshi
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (06): : 780 - 787
  • [38] Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody
    Phillips, Angela M.
    Maurer, Daniel P.
    Brooks, Caelan
    Dupic, Thomas
    Schmidt, Aaron G.
    Desai, Michael M.
    ELIFE, 2023, 12
  • [39] Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin
    Andrews, Sarah F.
    Chambers, Michael J.
    Schramm, Chaim A.
    Plyler, Jason
    Raab, Julie E.
    Kanekiyo, Masaru
    Gillespie, Rebecca A.
    Ransier, Amy
    Darko, Sam
    Hu, Jianfei
    Chen, Xuejun
    Yassine, Hadi M.
    Boyington, Jeffrey C.
    Crank, Michelle C.
    Chen, Grace L.
    Coates, Emily
    Mascola, John R.
    Douek, Daniel C.
    Graham, Barney S.
    Ledgerwood, Julie E.
    McDermott, Adrian B.
    IMMUNITY, 2019, 51 (02) : 398 - +
  • [40] Comparison of a Microfluidic Generic Total Antibody (TAb) Assay with Independent Neutralizing Antibody (NAb) and TAb Assays for the Detection of Pre-Existing Antibodies Against AAV Vectors
    Feeley, Eric
    Lothberg, Frida
    Hedstrom, Kira
    Rodo, Jordi
    Bovin, Lone Frier
    Celik, Selvi
    Klint, Cecilia
    Gianneli, Maria
    MOLECULAR THERAPY, 2024, 32 (04) : 434 - 434